FindTrial
Sign In

The effect of pericapsular nerve group (PENG) block combined with lateral femoral cutaneous nerve block and iliohypogastric nerve,ilioinguinal nerve block on postoperative analgesia after total hip arthroplasty: A Randomized Controlled Trial

The effect of pericapsular nerve group (PENG) block combined with lateral femoral cutaneous nerve block and iliohypogastric nerve,ilioinguinal nerve block on postoperative analgesia after total hip arthroplasty: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118106
Enrollment
Unknown
Registered
2026-02-02
Start date
2026-02-02
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgesia after total hip arthroplasty

Interventions

Experimental group:After the induction of general anesthesia, pericapsular nerve group (PENG) block combined with lateral femoral cutaneous nerve block and iliohypogastric nerve,ilioinguinal nerve bl
Control group:After the induction of general anesthesia, pericapsular nerve group (PENG) block combined with lateral femoral cutaneous nerve block will be performed only.

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients undergoing total hip arthroplasty (THA) via the posterolateral approach under general anesthesia 2. Age >= 18 years 3. Body Mass Index (BMI) <= 35 kg/m^2 4. American Society of Anesthesiologists (ASA) grade I-III

Exclusion criteria

Exclusion criteria: 1. Patients refuse to participate in the study. 2. Cognitive dysfunction or ineffective communication. 3. Limb amputation or paraplegia. 4. Presence of related diseases affecting the lower limb muscles (such as poliomyelitis, myasthenia gravis, polymyositis, etc.). 5.Contraindications of peripheral nerve block anesthesia (such as skin infection at the puncture site,coagulopathy, etc.). 6. Chronic pain, history of long-term use of analgesics or addiction to opioid drugs. 7. Allergy or intolerance to local anaesthetic. 8. Undergoing other surgical approaches. 9. Patients under spinal anesthesia. 10. Bilateral surgery or revision after joint replacement. 11. Currently participating in another intervention study that may affect the primary outcome.

Design outcomes

Primary

MeasureTime frame
Opioid consumption within 24 hours after surgery;—

Secondary

MeasureTime frame
The time of patient-controlled analgesia (PCA) be firstly pressed after surgery;Frequency of postoperative additional analgesia;The AUC of 24hVAS;Quality of postoperative Recovery score-15 (QoR-15);Categories and incidence rates of perioperative adverse events (AEs);—

Countries

China

Contacts

Public ContactYueying Zhang

The Affiliated Hospital of Xuzhou Medical University

zyy0218@126.com+86 180 5226 8602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026